The activities of the Prower-Stuart factor in the first and second phase of thromboplastin production were separately assayed in 100 normal persons and 50 Dindevan-treated patients. It was found that in some of the subjects examined the two activities varied independently, and that some of the normal persons presented a partial deficiency of the factor. The implications of these findings are discussed.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.